{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:38:10Z","timestamp":1787240290379,"version":"build-2736575974"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s10555-025-10242-w","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:45:56Z","timestamp":1737679556000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The diversity of natural killer cell functional and phenotypic states in cancer"],"prefix":"10.1007","volume":"44","author":[{"given":"Kumar","family":"Rishabh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Matosevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,24]]},"reference":[{"key":"10242_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.molimm.2022.02.015","volume":"144","author":"W Zhang","year":"2022","unstructured":"Zhang, W., Zhao, Z., & Li, F. (2022). Natural killer cell dysfunction in cancer and new strategies to utilize NK cell potential for cancer immunotherapy. Molecular Immunology, 144, 58\u201370.","journal-title":"Molecular Immunology"},{"key":"10242_CR2","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cytogfr.2020.12.003","volume":"59","author":"X Yao","year":"2021","unstructured":"Yao, X., & Matosevic, S. (2021). Chemokine networks modulating natural killer cell trafficking to solid tumors. Cytokine & Growth Factor Reviews, 59, 36\u201345.","journal-title":"Cytokine & Growth Factor Reviews"},{"key":"10242_CR3","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1158\/2326-6066.CIR-18-0481","volume":"7","author":"C Harmon","year":"2019","unstructured":"Harmon, C., et al. (2019). Lactate-mediated acidification of tumor microenvironment induces apoptosis of liver-resident NK Cells in colorectal liver metastasis. Cancer Immunology Research, 7, 335\u2013346.","journal-title":"Cancer Immunology Research"},{"key":"10242_CR4","doi-asserted-by":"crossref","unstructured":"Vitale, M., Cantoni, C., Pietra, G., Mingari, M. C. & Moretta, L. Effect of tumor cells and tumor microenvironment on NK-cell function. European Journal of Immunology 44, 1582\u20131592.","DOI":"10.1002\/eji.201344272"},{"key":"10242_CR5","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1172\/JCI125916","volume":"129","author":"A Merino","year":"2019","unstructured":"Merino, A., et al. (2019). Chronic stimulation drives human NK cell dysfunction and epigenetic reprograming. The Journal of Clinical Investigation, 129, 3770\u20133785.","journal-title":"The Journal of Clinical Investigation"},{"key":"10242_CR6","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.tips.2023.08.009","volume":"44","author":"S Borde","year":"2023","unstructured":"Borde, S., & Matosevic, S. (2023). Metabolic adaptation of NK cell activity and behavior in tumors: Challenges and therapeutic opportunities. Trends in Pharmacological Sciences, 44, 832\u2013848.","journal-title":"Trends in Pharmacological Sciences"},{"key":"10242_CR7","doi-asserted-by":"publisher","first-page":"5488","DOI":"10.1182\/blood-2008-10-187179","volume":"113","author":"L Chiossone","year":"2009","unstructured":"Chiossone, L., et al. (2009). Maturation of mouse NK cells is a 4-stage developmental program. Blood, 113, 5488\u20135496.","journal-title":"Blood"},{"key":"10242_CR8","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1002\/ijc.34389","volume":"152","author":"N Tumino","year":"2023","unstructured":"Tumino, N., et al. (2023). The tumor microenvironment drives NK cell metabolic dysfunction leading to impaired antitumor activity. International Journal of Cancer, 152, 1698\u20131706.","journal-title":"International Journal of Cancer"},{"key":"10242_CR9","doi-asserted-by":"crossref","unstructured":"Lupo, K. B. et al. TIGIT contributes to the regulation of 4\u20131BB and does not define NK cell dysfunction in glioblastoma. iScience 26, (2023).","DOI":"10.1016\/j.isci.2023.108353"},{"key":"10242_CR10","doi-asserted-by":"crossref","unstructured":"Ran, G. he et al. Natural killer cell homing and trafficking in tissues and tumors: From biology to application. Sig Transduct Target Ther 7, 1\u201321 (2022)","DOI":"10.1038\/s41392-022-01058-z"},{"key":"10242_CR11","doi-asserted-by":"publisher","first-page":"610789","DOI":"10.3389\/fimmu.2021.610789","volume":"12","author":"X Wang","year":"2021","unstructured":"Wang, X., & Zhao, X.-Y. (2021). Transcription factors associated with IL-15 cytokine signaling during NK cell development. Frontiers in Immunology, 12, 610789.","journal-title":"Frontiers in Immunology"},{"key":"10242_CR12","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1182\/blood.V87.7.2632.bloodjournal8772632","volume":"87","author":"E Mr\u00f3zek","year":"1996","unstructured":"Mr\u00f3zek, E., Anderson, P., & Caligiuri, M. A. (1996). Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells. Blood, 87, 2632\u20132640.","journal-title":"Blood"},{"key":"10242_CR13","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1182\/blood-2009-12-234096","volume":"115","author":"R Seggewiss","year":"2010","unstructured":"Seggewiss, R., & Einsele, H. (2010). Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: An update. Blood, 115, 3861\u20133868.","journal-title":"Blood"},{"key":"10242_CR14","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1182\/blood.V92.10.3647","volume":"92","author":"H Yu","year":"1998","unstructured":"Yu, H., et al. (1998). Flt3 ligand promotes the generation of a distinct CD34(+) human natural killer cell progenitor that responds to interleukin-15. Blood, 92, 3647\u20133657.","journal-title":"Blood"},{"key":"10242_CR15","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.gendis.2022.07.009","volume":"10","author":"L Wang","year":"2023","unstructured":"Wang, L., Chen, Z., Liu, G., & Pan, Y. (2023). Functional crosstalk and regulation of natural killer cells in tumor microenvironment: Significance and potential therapeutic strategies. Genes & Diseases, 10, 990\u20131004.","journal-title":"Genes & Diseases"},{"key":"10242_CR16","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s13402-020-00523-7","volume":"43","author":"J Wang","year":"2020","unstructured":"Wang, J., & Matosevic, S. (2020). Functional and metabolic targeting of natural killer cells to solid tumors. Cellular Oncology, 43, 577\u2013600.","journal-title":"Cellular Oncology"},{"key":"10242_CR17","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/j.celrep.2019.10.058","volume":"29","author":"A Pfefferle","year":"2019","unstructured":"Pfefferle, A., et al. (2019). Intra-lineage plasticity and functional reprogramming maintain natural killer cell repertoire diversity. Cell Reports, 29, 2284-2294.e4.","journal-title":"Cell Reports"},{"key":"10242_CR18","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","volume":"50","author":"E Batlle","year":"2019","unstructured":"Batlle, E., & Massagu\u00e9, J. (2019). Transforming grown factor-\u03b2 signaling in immunity and cancer. Immunity, 50, 924\u2013940.","journal-title":"Immunity"},{"key":"10242_CR19","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41586-023-06945-1","volume":"626","author":"E Vivier","year":"2024","unstructured":"Vivier, E., et al. (2024). Natural killer cell therapies. Nature, 626, 727\u2013736.","journal-title":"Nature"},{"key":"10242_CR20","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s12026-015-8664-y","volume":"62","author":"LS Angelo","year":"2015","unstructured":"Angelo, L. S., et al. (2015). Practical NK cell phenotyping and variability in healthy adults. Immunologic Research, 62, 341\u2013356.","journal-title":"Immunologic Research"},{"key":"10242_CR21","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","volume":"22","author":"MA Cooper","year":"2001","unstructured":"Cooper, M. A., Fehniger, T. A., & Caligiuri, M. A. (2001). The biology of human natural killer-cell subsets. Trends in Immunology, 22, 633\u2013640.","journal-title":"Trends in Immunology"},{"key":"10242_CR22","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ni1582","volume":"9","author":"E Vivier","year":"2008","unstructured":"Vivier, E., Tomasello, E., Baratin, M., Walzer, T., & Ugolini, S. (2008). Functions of natural killer cells. Nature Immunology, 9, 503\u2013510.","journal-title":"Nature Immunology"},{"key":"10242_CR23","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.3389\/fimmu.2019.01812","volume":"10","author":"C Di Vito","year":"2019","unstructured":"Di Vito, C., Mikulak, J., & Mavilio, D. (2019). On the way to become a natural killer cell. Frontiers in Immunology, 10, 1812.","journal-title":"Frontiers in Immunology"},{"key":"10242_CR24","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.it.2013.07.005","volume":"34","author":"J Yu","year":"2013","unstructured":"Yu, J., Freud, A. G., & Caligiuri, M. A. (2013). Location and cellular stages of natural killer cell development. Trends in Immunology, 34, 573\u2013582.","journal-title":"Trends in Immunology"},{"key":"10242_CR25","doi-asserted-by":"publisher","first-page":"4947","DOI":"10.4049\/jimmunol.178.8.4947","volume":"178","author":"C Romagnani","year":"2007","unstructured":"Romagnani, C., et al. (2007). CD56brightCD16\u2212 killer ig-like receptor\u2212 NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. The Journal of Immunology, 178, 4947\u20134955.","journal-title":"The Journal of Immunology"},{"key":"10242_CR26","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1365-2567.2008.03027.x","volume":"126","author":"A Poli","year":"2009","unstructured":"Poli, A., et al. (2009). CD56 bright natural killer (NK) cells: An important NK cell subset. Immunology, 126, 458\u2013465.","journal-title":"Immunology"},{"key":"10242_CR27","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.4049\/jimmunol.172.3.1455","volume":"172","author":"G Ferlazzo","year":"2004","unstructured":"Ferlazzo, G., et al. (2004). The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-Like receptors and become cytolytic. The Journal of Immunology, 172, 1455\u20131462.","journal-title":"The Journal of Immunology"},{"key":"10242_CR28","doi-asserted-by":"crossref","unstructured":"Lugli, E., Marcenaro, E. & Mavilio, D. NK cell subset redistribution during the course of viral infections. Front. Immunol. 5, (2014).","DOI":"10.3389\/fimmu.2014.00390"},{"key":"10242_CR29","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.immuni.2015.02.008","volume":"42","author":"H Schlums","year":"2015","unstructured":"Schlums, H., et al. (2015). Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function. Immunity, 42, 443\u2013456.","journal-title":"Immunity"},{"key":"10242_CR30","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1053\/j.seminhematol.2020.11.003","volume":"57","author":"M Gang","year":"2020","unstructured":"Gang, M., Wong, P., Berrien-Elliott, M. M., & Fehniger, T. A. (2020). Memory-like natural killer cells for cancer immunotherapy. Seminars in Hematology, 57, 185\u2013193.","journal-title":"Seminars in Hematology"},{"key":"10242_CR31","doi-asserted-by":"publisher","first-page":"884648","DOI":"10.3389\/fimmu.2022.884648","volume":"13","author":"I Terr\u00e9n","year":"2022","unstructured":"Terr\u00e9n, I., et al. (2022). Cytokine-induced memory-like NK cells: From the basics to clinical applications. Frontiers in Immunology, 13, 884648.","journal-title":"Frontiers in Immunology"},{"key":"10242_CR32","doi-asserted-by":"publisher","unstructured":"Rebuffet, L. et al. High-dimensional single-cell analysis of human natural killer cell heterogeneity. Nat Immunol 1\u201315 (2024) https:\/\/doi.org\/10.1038\/s41590-024-01883-0.","DOI":"10.1038\/s41590-024-01883-0"},{"key":"10242_CR33","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1182\/bloodadvances.2019000699","volume":"4","author":"SL Smith","year":"2020","unstructured":"Smith, S. L., et al. (2020). Diversity of peripheral blood human NK cells identified by single-cell RNA sequencing. Blood Advances, 4, 1388\u20131406.","journal-title":"Blood Advances"},{"key":"10242_CR34","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1146\/annurev.immunol.16.1.359","volume":"16","author":"LL Lanier","year":"1998","unstructured":"Lanier, L. L. (1998). NK cell receptors. Annual Review of Immunology, 16, 359\u2013393.","journal-title":"Annual Review of Immunology"},{"key":"10242_CR35","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev.immunol.19.1.197","volume":"19","author":"A Moretta","year":"2001","unstructured":"Moretta, A., et al. (2001). Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annual Review of Immunology, 19, 197\u2013223.","journal-title":"Annual Review of Immunology"},{"key":"10242_CR36","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.1182\/blood-2010-04-281675","volume":"116","author":"NK Bj\u00f6rkstr\u00f6m","year":"2010","unstructured":"Bj\u00f6rkstr\u00f6m, N. K., et al. (2010). Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood, 116, 3853\u20133864.","journal-title":"Blood"},{"key":"10242_CR37","doi-asserted-by":"crossref","unstructured":"Biassoni, R. Natural killer cell receptors. in Multichain immune recognition receptor signaling (ed. Sigalov, A. B.) vol. 640 35\u201352 (Springer New York, New York, NY, 2008).","DOI":"10.1007\/978-0-387-09789-3_4"},{"key":"10242_CR38","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1084\/jem.187.12.2065","volume":"187","author":"M Vitale","year":"1998","unstructured":"Vitale, M., et al. (1998). NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. Journal of Experimental Medicine, 187, 2065\u20132072.","journal-title":"Journal of Experimental Medicine"},{"key":"10242_CR39","doi-asserted-by":"crossref","unstructured":"Hudspeth, K., Silva-Santos, B. & Mavilio, D. Natural cytotoxicity receptors: Broader Expression patterns and functions in innate and adaptive immune cells. Front. Immunol. 4, (2013).","DOI":"10.3389\/fimmu.2013.00069"},{"key":"10242_CR40","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1084\/jem.20030305","volume":"198","author":"LA Koopman","year":"2003","unstructured":"Koopman, L. A., et al. (2003). Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. The Journal of Experimental Medicine, 198, 1201\u20131212.","journal-title":"The Journal of Experimental Medicine"},{"key":"10242_CR41","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.4049\/jimmunol.168.6.2745","volume":"168","author":"J Rachmilewitz","year":"2002","unstructured":"Rachmilewitz, J., et al. (2002). Focal localization of placental protein 14 toward sites of TCR engagement. The Journal of Immunology, 168, 2745\u20132750.","journal-title":"The Journal of Immunology"},{"key":"10242_CR42","doi-asserted-by":"crossref","unstructured":"L\u00f6gdberg, L. & Wester, L. Immunocalins: A lipocalin subfamily that modulates immune and inflammatory responses. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology 1482, 284\u2013297 (2000).","DOI":"10.1016\/S0167-4838(00)00164-3"},{"key":"10242_CR43","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/nri.2016.34","volume":"16","author":"NK Bj\u00f6rkstr\u00f6m","year":"2016","unstructured":"Bj\u00f6rkstr\u00f6m, N. K., Ljunggren, H.-G., & Micha\u00eblsson, J. (2016). Emerging insights into natural killer cells in human peripheral tissues. Nature Reviews Immunology, 16, 310\u2013320.","journal-title":"Nature Reviews Immunology"},{"key":"10242_CR44","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.immuni.2017.10.008","volume":"47","author":"AG Freud","year":"2017","unstructured":"Freud, A. G., Mundy-Bosse, B. L., Yu, J., & Caligiuri, M. A. (2017). The broad spectrum of human natural killer cell diversity. Immunity, 47, 820\u2013833.","journal-title":"Immunity"},{"key":"10242_CR45","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.4049\/jimmunol.1301889","volume":"192","author":"P Carrega","year":"2014","unstructured":"Carrega, P., et al. (2014). CD56brightperforinlow noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph. The Journal of Immunology, 192, 3805\u20133815.","journal-title":"The Journal of Immunology"},{"key":"10242_CR46","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1172\/JCI111513","volume":"74","author":"BW Robinson","year":"1984","unstructured":"Robinson, B. W., Pinkston, P., & Crystal, R. G. (1984). Natural killer cells are present in the normal human lung but are functionally impotent. The Journal of Clinical Investigation, 74, 942\u2013950.","journal-title":"The Journal of Clinical Investigation"},{"key":"10242_CR47","doi-asserted-by":"crossref","unstructured":"Wiedemann, G. M. Localization matters: Epigenetic regulation of natural killer cells in different tissue microenvironments. Front. Immunol. 13, (2022).","DOI":"10.3389\/fimmu.2022.913054"},{"key":"10242_CR48","doi-asserted-by":"crossref","unstructured":"Stary, V. et al. A discrete subset of epigenetically primed human NK cells mediates antigen-specific immune responses. Sci. Immunol. 5, eaba6232 (2020).","DOI":"10.1126\/sciimmunol.aba6232"},{"key":"10242_CR49","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.it.2011.06.013","volume":"32","author":"P Vacca","year":"2011","unstructured":"Vacca, P., Moretta, L., Moretta, A., & Mingari, M. C. (2011). Origin, phenotype and function of human natural killer cells in pregnancy. Trends in Immunology, 32, 517\u2013523.","journal-title":"Trends in Immunology"},{"key":"10242_CR50","doi-asserted-by":"crossref","unstructured":"Vacca, P., Chiossone, L., Mingari, M. C. & Moretta, L. Heterogeneity of NK cells and other innate lymphoid cells in human and murine decidua. Front. Immunol. 10, (2019).","DOI":"10.3389\/fimmu.2019.00170"},{"key":"10242_CR51","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/nm1452","volume":"12","author":"J Hanna","year":"2006","unstructured":"Hanna, J., et al. (2006). Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nature Medicine, 12, 1065\u20131074.","journal-title":"Nature Medicine"},{"key":"10242_CR52","doi-asserted-by":"publisher","first-page":"15563","DOI":"10.1073\/pnas.0507835102","volume":"102","author":"HD Kopcow","year":"2005","unstructured":"Kopcow, H. D., et al. (2005). Human decidual NK cells form immature activating synapses and are not cytotoxic. Proceedings of the National academy of Sciences of the United States of America, 102, 15563\u201315568.","journal-title":"Proceedings of the National academy of Sciences of the United States of America"},{"key":"10242_CR53","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00262-009-0724-5","volume":"59","author":"MJ Szczepanski","year":"2010","unstructured":"Szczepanski, M. J., et al. (2010). Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors. Cancer Immunology, Immunotherapy, 59, 73\u201379.","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"10242_CR54","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1182\/blood.V99.10.3661","volume":"99","author":"RT Costello","year":"2002","unstructured":"Costello, R. T., et al. (2002). Defective expression and function of natural killer cell\u2013triggering receptors in patients with acute myeloid leukemia. Blood, 99, 3661\u20133667.","journal-title":"Blood"},{"key":"10242_CR55","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1182\/blood-2005-08-027979","volume":"109","author":"C Fauriat","year":"2007","unstructured":"Fauriat, C., et al. (2007). Deficient expression of NCR in NK cells from acute myeloid leukemia: Evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction. Blood, 109, 323\u2013330.","journal-title":"Blood"},{"key":"10242_CR56","doi-asserted-by":"publisher","first-page":"e2020459118","DOI":"10.1073\/pnas.2020459118","volume":"118","author":"A-S Chretien","year":"2021","unstructured":"Chretien, A.-S., et al. (2021). High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome. Proc Natl Acad Sci U S A, 118, e2020459118.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10242_CR57","doi-asserted-by":"publisher","first-page":"e2020459118","DOI":"10.1073\/pnas.2020459118","volume":"118","author":"A-S Chretien","year":"2021","unstructured":"Chretien, A.-S., et al. (2021). High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome. Proceedings of the National Academy of Sciences of the United States of America, 118, e2020459118.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10242_CR58","doi-asserted-by":"publisher","first-page":"5412","DOI":"10.1158\/0008-5472.CAN-10-4179","volume":"71","author":"S Platonova","year":"2011","unstructured":"Platonova, S., et al. (2011). Profound coordinated alterations of intratumoral NK cell phenotype and function in lung carcinoma. Cancer Research, 71, 5412\u20135422.","journal-title":"Cancer Research"},{"key":"10242_CR59","doi-asserted-by":"publisher","first-page":"e1264562","DOI":"10.1080\/2162402X.2016.1264562","volume":"6","author":"C Sun","year":"2017","unstructured":"Sun, C., et al. (2017). High NKG2A expression contributes to NK cell exhaustion and predicts a poor prognosis of patients with liver cancer. OncoImmunology, 6, e1264562.","journal-title":"OncoImmunology"},{"key":"10242_CR60","doi-asserted-by":"publisher","first-page":"e76928","DOI":"10.1371\/journal.pone.0076928","volume":"8","author":"G Fregni","year":"2013","unstructured":"Fregni, G., et al. (2013). Phenotypic and functional characteristics of blood natural killer cells from melanoma patients at different clinical stages. PLoS ONE, 8, e76928.","journal-title":"PLoS ONE"},{"key":"10242_CR61","doi-asserted-by":"crossref","unstructured":"Mirja\u010di\u0107 Martinovi\u0107, K., Konjevi\u0107, G., Babovi\u0107, N. & Ini\u0107, M. The stage dependent changes in NK cell activity and the expression of activating and inhibitory NK cell receptors in melanoma patients. Journal of Surgical Research 171, 637\u2013649 (2011).","DOI":"10.1016\/j.jss.2010.05.012"},{"key":"10242_CR62","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1172\/JCI45816","volume":"121","author":"E Mamessier","year":"2011","unstructured":"Mamessier, E., et al. (2011). Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity. The Journal of Clinical Investigation, 121, 3609\u20133622.","journal-title":"The Journal of Clinical Investigation"},{"key":"10242_CR63","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00262-019-02343-7","volume":"68","author":"D Krijgsman","year":"2019","unstructured":"Krijgsman, D., et al. (2019). Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: The peripheral blood immune cell profile. Cancer Immunology, Immunotherapy, 68, 1011\u20131024.","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"10242_CR64","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1177\/1753425912453187","volume":"19","author":"YS Rocca","year":"2013","unstructured":"Rocca, Y. S., et al. (2013). Altered phenotype in peripheral blood and tumor-associated NK cells from colorectal cancer patients. Innate Immunity, 19, 76\u201385.","journal-title":"Innate Immunity"},{"key":"10242_CR65","doi-asserted-by":"crossref","unstructured":"Rocca, Y. S. et al. Phenotypic and functional dysregulated blood NK cells in colorectal cancer patients can be activated by cetuximab plus IL-2 or IL-15. Front. Immunol. 7, (2016).","DOI":"10.3389\/fimmu.2016.00413"},{"key":"10242_CR66","doi-asserted-by":"publisher","first-page":"1993042","DOI":"10.1080\/2162402X.2021.1993042","volume":"11","author":"MH Lee","year":"2022","unstructured":"Lee, M. H., et al. (2022). T and NK cell abundance defines two distinct subgroups of renal cell carcinoma. OncoImmunology, 11, 1993042.","journal-title":"OncoImmunology"},{"key":"10242_CR67","doi-asserted-by":"publisher","first-page":"1845424","DOI":"10.1080\/2162402X.2020.1845424","volume":"9","author":"F Marcon","year":"2020","unstructured":"Marcon, F., et al. (2020). NK cells in pancreatic cancer demonstrate impaired cytotoxicity and a regulatory IL-10 phenotype. OncoImmunology, 9, 1845424.","journal-title":"OncoImmunology"},{"key":"10242_CR68","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/j.1365-2567.2007.02660.x","volume":"122","author":"JA Belisle","year":"2007","unstructured":"Belisle, J. A., et al. (2007). Peritoneal natural killer cells from epithelial ovarian cancer patients show an altered phenotype and bind to the tumour marker MUC16 (CA125). Immunology, 122, 418\u2013429.","journal-title":"Immunology"},{"key":"10242_CR69","doi-asserted-by":"crossref","unstructured":"Degos, C. et al. Endometrial tumor microenvironment alters human NK cell recruitment, and resident NK cell phenotype and function. Front. Immunol. 10, (2019).","DOI":"10.3389\/fimmu.2019.00877"},{"key":"10242_CR70","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.3389\/fimmu.2018.02324","volume":"9","author":"R Castriconi","year":"2018","unstructured":"Castriconi, R., et al. (2018). Molecular mechanisms directing migration and retention of natural killer cells in human tissues. Frontiers in Immunology, 9, 2324.","journal-title":"Frontiers in Immunology"},{"key":"10242_CR71","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.3389\/fimmu.2019.03038","volume":"10","author":"O Melaiu","year":"2020","unstructured":"Melaiu, O., Lucarini, V., Cifaldi, L., & Fruci, D. (2020). Influence of the tumor microenvironment on NK cell function in solid tumors. Frontiers in Immunology, 10, 3038.","journal-title":"Frontiers in Immunology"},{"key":"10242_CR72","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.3389\/fimmu.2018.02517","volume":"9","author":"AM Chambers","year":"2018","unstructured":"Chambers, A. M., Lupo, K. B., & Matosevic, S. (2018). Tumor microenvironment-induced immunometabolic reprogramming of natural killer cells. Frontiers in Immunology, 9, 2517.","journal-title":"Frontiers in Immunology"},{"key":"10242_CR73","doi-asserted-by":"publisher","first-page":"586126","DOI":"10.3389\/fimmu.2020.586126","volume":"11","author":"M Gallazzi","year":"2021","unstructured":"Gallazzi, M., et al. (2021). Prostate cancer peripheral blood NK cells show enhanced CD9, CD49a, CXCR4, CXCL8, MMP-9 production and secrete monocyte-recruiting and polarizing factors. Frontiers in Immunology, 11, 586126.","journal-title":"Frontiers in Immunology"},{"key":"10242_CR74","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1158\/0008-5472.CAN-15-1965","volume":"76","author":"C Pasero","year":"2016","unstructured":"Pasero, C., et al. (2016). Inherent and tumor-driven immune tolerance in the prostate microenvironment impairs natural killer cell antitumor activity. Cancer Research, 76, 2153\u20132165.","journal-title":"Cancer Research"},{"key":"10242_CR75","doi-asserted-by":"crossref","unstructured":"Bruno, A. et al. The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer. Neoplasia 15, 133-IN7 (2013).","DOI":"10.1593\/neo.121758"},{"key":"10242_CR76","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/cncr.23239","volume":"112","author":"P Carrega","year":"2008","unstructured":"Carrega, P., et al. (2008). Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56brightCD16\u2212 cells and display an impaired capability to kill tumor cells. Cancer, 112, 863\u2013875.","journal-title":"Cancer"},{"key":"10242_CR77","doi-asserted-by":"publisher","first-page":"1191884","DOI":"10.3389\/fimmu.2023.1191884","volume":"14","author":"V Im\u0161irovi\u0107","year":"2023","unstructured":"Im\u0161irovi\u0107, V., Lenarti\u0107, M., Wensveen, F. M., Poli\u0107, B., & Jelen\u010di\u0107, V. (2023). Largely preserved functionality after the combined loss of NKG2D, NCR1 and CD16 demonstrates the remarkable plasticity of NK cell responsiveness. Frontiers in Immunology, 14, 1191884.","journal-title":"Frontiers in Immunology"},{"key":"10242_CR78","doi-asserted-by":"publisher","first-page":"e202001134","DOI":"10.1083\/jcb.202001134","volume":"219","author":"IS Chan","year":"2020","unstructured":"Chan, I. S., et al. (2020). Cancer cells educate natural killer cells to a metastasis-promoting cell state. Journal of Cell Biology, 219, e202001134.","journal-title":"Journal of Cell Biology"},{"key":"10242_CR79","doi-asserted-by":"publisher","first-page":"101273","DOI":"10.1016\/j.smim.2019.04.001","volume":"41","author":"T Bald","year":"2019","unstructured":"Bald, T., Wagner, M., Gao, Y., Koyasu, S., & Smyth, M. J. (2019). Hide and seek: Plasticity of innate lymphoid cells in cancer. Seminars in Immunology, 41, 101273.","journal-title":"Seminars in Immunology"},{"key":"10242_CR80","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/ni.3800","volume":"18","author":"Y Gao","year":"2017","unstructured":"Gao, Y., et al. (2017). Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells. Nature Immunology, 18, 1004\u20131015.","journal-title":"Nature Immunology"},{"key":"10242_CR81","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/sj.bjc.6603877","volume":"97","author":"LJAC Hawinkels","year":"2007","unstructured":"Hawinkels, L. J. A. C., et al. (2007). Tissue level, activation and cellular localisation of TGF-\u03b21 and association with survival in gastric cancer patients. British Journal of Cancer, 97, 398\u2013404.","journal-title":"British Journal of Cancer"},{"key":"10242_CR82","doi-asserted-by":"publisher","first-page":"e2101169118","DOI":"10.1073\/pnas.2101169118","volume":"118","author":"UY Moreno-Nieves","year":"2021","unstructured":"Moreno-Nieves, U. Y., et al. (2021). Landscape of innate lymphoid cells in human head and neck cancer reveals divergent NK cell states in the tumor microenvironment. Proceedings of the National academy of Sciences of the United States of America, 118, e2101169118.","journal-title":"Proceedings of the National academy of Sciences of the United States of America"},{"key":"10242_CR83","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12943-023-01737-7","volume":"22","author":"Y Zhou","year":"2023","unstructured":"Zhou, Y., Cheng, L., Liu, L., & Li, X. (2023). NK cells are never alone: Crosstalk and communication in tumour microenvironments. Molecular Cancer, 22, 34.","journal-title":"Molecular Cancer"},{"key":"10242_CR84","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/s41467-024-44789-z","volume":"15","author":"I Dean","year":"2024","unstructured":"Dean, I., et al. (2024). Rapid functional impairment of natural killer cells following tumor entry limits anti-tumor immunity. Nature Communications, 15, 683.","journal-title":"Nature Communications"},{"key":"10242_CR85","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.cmet.2021.03.023","volume":"33","author":"SM Poznanski","year":"2021","unstructured":"Poznanski, S. M., et al. (2021). Metabolic flexibility determines human NK cell functional fate in the tumor microenvironment. Cell Metabolism, 33, 1205-1220.e5.","journal-title":"Cell Metabolism"},{"key":"10242_CR86","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/imm.13464","volume":"166","author":"K Roe","year":"2022","unstructured":"Roe, K. (2022). NK-cell exhaustion, B-cell exhaustion and T-cell exhaustion\u2014The differences and similarities. Immunology, 166, 155\u2013168.","journal-title":"Immunology"},{"key":"10242_CR87","doi-asserted-by":"crossref","unstructured":"Myers, J. A. et al. Balanced engagement of activating and inhibitory receptors mitigates human NK cell exhaustion. JCI Insight 7, (2022).","DOI":"10.1172\/jci.insight.150079"},{"key":"10242_CR88","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.immuni.2006.06.013","volume":"25","author":"N Anfossi","year":"2006","unstructured":"Anfossi, N., et al. (2006). Human NK cell education by inhibitory receptors for MHC class I. Immunity, 25, 331\u2013342.","journal-title":"Immunity"},{"key":"10242_CR89","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1084\/jem.20100570","volume":"207","author":"NT Joncker","year":"2010","unstructured":"Joncker, N. T., Shifrin, N., Delebecque, F., & Raulet, D. H. (2010). Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment. Journal of Experimental Medicine, 207, 2065\u20132072.","journal-title":"Journal of Experimental Medicine"},{"key":"10242_CR90","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.it.2009.01.006","volume":"30","author":"P Brodin","year":"2009","unstructured":"Brodin, P., K\u00e4rre, K., & H\u00f6glund, P. (2009). NK cell education: Not an on-off switch but a tunable rheostat. Trends in Immunology, 30, 143\u2013149.","journal-title":"Trends in Immunology"},{"key":"10242_CR91","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1007\/s00262-018-2235-8","volume":"67","author":"C Yang","year":"2018","unstructured":"Yang, C., et al. (2018). Anergic natural killer cells educated by tumor cells are associated with a poor prognosis in patients with advanced pancreatic ductal adenocarcinoma. Cancer Immunology, Immunotherapy, 67, 1815\u20131823.","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"10242_CR92","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.cell.2020.01.022","volume":"180","author":"P Dogra","year":"2020","unstructured":"Dogra, P., et al. (2020). Tissue determinants of human NK cell development, function, and residence. Cell, 180, 749-763.e13.","journal-title":"Cell"},{"key":"10242_CR93","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1038\/s44318-024-00094-5","volume":"43","author":"B Sabag","year":"2024","unstructured":"Sabag, B., et al. (2024). Dysfunctional natural killer cells can be reprogrammed to regain anti-tumor activity. The EMBO Journal, 43, 2552\u20132581.","journal-title":"The EMBO Journal"},{"key":"10242_CR94","doi-asserted-by":"publisher","first-page":"22310","DOI":"10.18632\/oncotarget.4208","volume":"6","author":"\u0160 Magister","year":"2015","unstructured":"Magister, \u0160, Tseng, H.-C., Bui, V. T., Kos, J., & Jewett, A. (2015). Regulation of split anergy in natural killer cells by inhibition of cathepsins C and H and cystatin F. Oncotarget, 6, 22310\u201322327.","journal-title":"Oncotarget"},{"key":"10242_CR95","doi-asserted-by":"publisher","first-page":"8947","DOI":"10.18632\/oncotarget.3250","volume":"6","author":"H-C Tseng","year":"2015","unstructured":"Tseng, H.-C., Cacalano, N., & Jewett, A. (2015). Split anergized natural killer cells halt inflammation by inducing stem cell differentiation, resistance to NK cell cytotoxicity and prevention of cytokine and chemokine secretion. Oncotarget, 6, 8947\u20138959.","journal-title":"Oncotarget"},{"key":"10242_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-022-03402-z","volume":"5","author":"B Breznik","year":"2022","unstructured":"Breznik, B., et al. (2022). Infiltrating natural killer cells bind, lyse and increase chemotherapy efficacy in glioblastoma stem-like tumorospheres. Commun Biol, 5, 1\u201315.","journal-title":"Commun Biol"},{"key":"10242_CR97","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1158\/1078-0432.CCR-05-2306","volume":"12","author":"A Jewett","year":"2006","unstructured":"Jewett, A., Cacalano, N. A., Head, C., & Teruel, A. (2006). Coengagement of CD16 and CD94 receptors mediates secretion of chemokines and induces apoptotic death of naive natural killer cells. Clinical Cancer Research, 12, 1994\u20132003.","journal-title":"Clinical Cancer Research"},{"key":"10242_CR98","doi-asserted-by":"publisher","first-page":"4781","DOI":"10.1172\/JCI74337","volume":"124","author":"M Ardolino","year":"2014","unstructured":"Ardolino, M., et al. (2014). Cytokine therapy reverses NK cell anergy in MHC-deficient tumors. The Journal of Clinical Investigation, 124, 4781\u20134794.","journal-title":"The Journal of Clinical Investigation"},{"key":"10242_CR99","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s002620050609","volume":"49","author":"S Das","year":"2000","unstructured":"Das, S., Varalakshmi, C., & Khar, A. (2000). Target-cell-induced anergy in natural killer cells: Suppression of cytotoxic function. Cancer Immunology, Immunotherapy, 49, 109\u2013115.","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"10242_CR100","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.3324\/haematol.2017.186619","volume":"103","author":"A Roberto","year":"2018","unstructured":"Roberto, A., et al. (2018). The early expansion of anergic NKG2Apos\/CD56dim\/CD16neg natural killer represents a therapeutic target in haploidentical hematopoietic stem cell transplantation. Haematologica, 103, 1390\u20131402.","journal-title":"Haematologica"},{"key":"10242_CR101","doi-asserted-by":"publisher","first-page":"7","DOI":"10.21037\/sci.2019.02.04","volume":"6","author":"E Fathi","year":"2019","unstructured":"Fathi, E., Charoudeh, H. N., Sanaat, Z., & Farahzadi, R. (2019). Telomere shortening as a hallmark of stem cell senescence. Stem Cell Investigation, 6, 7.","journal-title":"Stem Cell Investigation"},{"key":"10242_CR102","doi-asserted-by":"publisher","first-page":"15653","DOI":"10.3390\/ijms242115653","volume":"24","author":"YS Martyshkina","year":"2023","unstructured":"Martyshkina, Y. S., Tereshchenko, V. P., Bogdanova, D. A., & Rybtsov, S. A. (2023). Reliable hallmarks and biomarkers of senescent lymphocytes. International Journal of Molecular Sciences, 24, 15653.","journal-title":"International Journal of Molecular Sciences"},{"key":"10242_CR103","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.arr.2013.04.003","volume":"12","author":"J Hazeldine","year":"2013","unstructured":"Hazeldine, J., & Lord, J. M. (2013). The impact of ageing on natural killer cell function and potential consequences for health in older adults. Ageing Research Reviews, 12, 1069\u20131078.","journal-title":"Ageing Research Reviews"},{"key":"10242_CR104","doi-asserted-by":"publisher","first-page":"20596","DOI":"10.1073\/pnas.1208248109","volume":"109","author":"S Rajagopalan","year":"2012","unstructured":"Rajagopalan, S., & Long, E. O. (2012). Cellular senescence induced by CD158d reprograms natural killer cells to promote vascular remodeling. Proceedings of the National Academy of Sciences, 109, 20596\u201320601.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10242_CR105","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/imm.13173","volume":"159","author":"LP Covre","year":"2020","unstructured":"Covre, L. P., et al. (2020). Compartmentalized cytotoxic immune response leads to distinct pathogenic roles of natural killer and senescent CD8+ T cells in human cutaneous leishmaniasis. Immunology, 159, 429\u2013440.","journal-title":"Immunology"},{"key":"10242_CR106","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.stemcr.2017.06.020","volume":"9","author":"RM Petri","year":"2017","unstructured":"Petri, R. M., et al. (2017). Activated tissue-resident mesenchymal stromal cells regulate natural killer cell immune and tissue-regenerative function. Stem Cell Reports, 9, 985.","journal-title":"Stem Cell Reports"},{"key":"10242_CR107","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41423-024-01145-x","volume":"21","author":"A Page","year":"2024","unstructured":"Page, A., Chuvin, N., Valladeau-Guilemond, J., & Depil, S. (2024). Development of NK cell-based cancer immunotherapies through receptor engineering. Cellular & Molecular Immunology, 21, 315\u2013331.","journal-title":"Cellular & Molecular Immunology"},{"key":"10242_CR108","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13045-022-01382-5","volume":"15","author":"N Lamers-Kok","year":"2022","unstructured":"Lamers-Kok, N., et al. (2022). Natural killer cells in clinical development as non-engineered, engineered, and combination therapies. Journal of Hematology & Oncology, 15, 164.","journal-title":"Journal of Hematology & Oncology"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-025-10242-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10555-025-10242-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-025-10242-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T23:27:35Z","timestamp":1743463655000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10555-025-10242-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":108,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10242"],"URL":"https:\/\/doi.org\/10.1007\/s10555-025-10242-w","relation":{},"ISSN":["0167-7659","1573-7233"],"issn-type":[{"value":"0167-7659","type":"print"},{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,24]]},"assertion":[{"value":"12 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}